ISRG: Intuitive Surgical, Inc. Financials
Intuitive Surgical, Inc. Income Statement
Total revenue
Net income
Gross margin TTM
66%
Operating margin TTM
29.27%
Net profit margin TTM
28.38%
Return on investment TTM
16.02%
| Period end | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 |
|---|---|---|---|---|
| Total revenue | 10,064,700,000 | 8,352,100,000 | 7,124,100,000 | 6,222,200,000 |
| Operating income | 2,945,500,000 | 2,348,900,000 | 1,766,800,000 | 1,577,100,000 |
| Net income | 2,856,000,000 | 2,322,600,000 | 1,798,000,000 | 1,322,300,000 |
All line items
| Line item | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 |
|---|---|---|---|---|
| Total revenue | 10,064,700,000 | 8,352,100,000 | 7,124,100,000 | 6,222,200,000 |
| Cost of revenue | 3,422,400,000 | 2,717,900,000 | 2,394,600,000 | 2,026,200,000 |
| Gross profit | 6,642,300,000 | 5,634,200,000 | 4,729,500,000 | 4,196,000,000 |
| Research and development expenses | 1,311,800,000 | 1,145,300,000 | 998,800,000 | 879,000,000 |
| General and administrative expenses | 0 | 0 | 0 | 0 |
| Selling and marketing expenses | 0 | 0 | 0 | 0 |
| Selling, general and administrative expenses | 2,385,000,000 | 2,140,000,000 | 1,963,900,000 | 1,739,900,000 |
| Other expenses | 0 | 0 | 0 | 0 |
| Operating expenses | 3,696,800,000 | 3,285,300,000 | 2,962,700,000 | 2,618,900,000 |
| Cost and expenses | 7,119,200,000 | 6,003,200,000 | 5,357,300,000 | 4,645,100,000 |
| Net interest income | 365,900,000 | 324,900,000 | 192,100,000 | 29,700,000 |
| Interest income | 365,900,000 | 324,900,000 | 192,100,000 | 29,700,000 |
| Interest expense | 0 | 0 | 0 | 0 |
| Depreciation and amortization | 677,100,000 | 462,000,000 | 402,200,000 | 365,800,000 |
| EBITDA | 3,988,500,000 | 3,135,800,000 | 2,361,100,000 | 1,972,600,000 |
| EBIT | 3,311,400,000 | 2,673,800,000 | 1,958,900,000 | 1,606,800,000 |
| Non-operating income (excl. interest) | -365,900,000 | -324,900,000 | -192,100,000 | -29,700,000 |
| Operating income | 2,945,500,000 | 2,348,900,000 | 1,766,800,000 | 1,577,100,000 |
| Total other income/expenses (net) | 365,900,000 | 324,900,000 | 192,100,000 | 29,700,000 |
| Income before tax | 3,311,400,000 | 2,673,800,000 | 1,958,900,000 | 1,606,800,000 |
| Income tax expense | 434,800,000 | 336,300,000 | 141,600,000 | 262,400,000 |
| Net income from continuing operations | 2,876,600,000 | 2,337,500,000 | 1,817,300,000 | 1,344,400,000 |
| Net income from discontinued operations | 0 | 0 | 0 | 0 |
| Other adjustments to net income | 0 | 0 | 0 | 0 |
| Net income | 2,856,000,000 | 2,322,600,000 | 1,798,000,000 | 1,322,300,000 |
| Net income deductions | 0 | 0 | 0 | 0 |
| Bottom line net income | 2,856,000,000 | 2,322,600,000 | 1,798,000,000 | 1,322,300,000 |
| EPS | 8 | 7 | 5 | 4 |
| Diluted EPS | 8 | 6 | 5 | 4 |
| Weighted average shares outstanding | 356,900,000 | 355,200,000 | 351,200,000 | 355,700,000 |
| Weighted average diluted shares outstanding | 362,700,000 | 362,000,000 | 357,400,000 | 362,000,000 |
Intuitive Surgical, Inc. Balance Sheet
Total assets
Total liabilities & equity
Liquidity ratio MRQ
—
Current ratio MRQ
—
Long-term debt / assets MRQ
131,900,000%
Total debt / assets MRQ
—
| Period end | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 |
|---|---|---|---|---|
| Total assets | 20,631,200,000 | 18,838,600,000 | 15,441,500,000 | 12,974,000,000 |
| Total liabilities | 2,689,500,000 | 2,309,000,000 | 2,044,200,000 | 1,861,400,000 |
| Total equity | 17,824,000,000 | 16,433,700,000 | 13,307,600,000 | 11,041,900,000 |
All line items
| Line item | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 |
|---|---|---|---|---|
| Cash and cash equivalents | 3,368,000,000 | 2,027,400,000 | 2,750,100,000 | 1,581,200,000 |
| Short-term investments | 2,566,900,000 | 1,985,900,000 | 2,473,100,000 | 2,541,000,000 |
| Cash and short-term investments | 5,934,900,000 | 4,013,300,000 | 5,223,200,000 | 4,117,900,000 |
| Net receivables | 1,628,200,000 | 1,356,800,000 | 1,267,500,000 | 1,073,300,000 |
| Accounts receivable | 1,527,300,000 | 1,225,400,000 | 1,130,200,000 | 942,100,000 |
| Other receivables | 100,900,000 | 131,400,000 | 137,300,000 | 131,200,000 |
| Inventory | 1,840,000,000 | 1,487,200,000 | 1,220,600,000 | 893,200,000 |
| Prepaid expenses | 0 | 0 | 0 | 162,500,000 |
| Other current assets | 376,400,000 | 253,700,000 | 176,700,000 | 6,100,000 |
| Total current assets | 9,779,500,000 | 7,111,000,000 | 7,888,000,000 | 6,253,000,000 |
| Property, plant and equipment (net) | 5,342,400,000 | 4,783,000,000 | 3,537,600,000 | 2,374,200,000 |
| Goodwill | 370,300,000 | 347,500,000 | 348,700,000 | 348,500,000 |
| Intangible assets | 11,100,000 | 23,000,000 | 39,100,000 | 49,800,000 |
| Goodwill and intangible assets | 381,400,000 | 370,500,000 | 387,800,000 | 398,300,000 |
| Long-term investments | 3,298,500,000 | 5,064,600,000 | 2,120,000,000 | 2,623,600,000 |
| Tax assets | 1,018,600,000 | 1,140,500,000 | 910,500,000 | 664,600,000 |
| Other non-current assets | 810,800,000 | 368,999,999 | 597,600,000 | 660,300,000 |
| Total non-current assets | 10,851,700,000 | 11,727,599,999 | 7,553,500,000 | 6,721,000,000 |
| Other assets | 0 | 0 | 0 | 0 |
| Total assets | 20,631,200,000 | 18,838,600,000 | 15,441,500,000 | 12,974,000,000 |
| Total payables | 380,500,000 | 347,800,000 | 300,100,000 | 243,100,000 |
| Accounts payable | 255,100,000 | 193,400,000 | 188,700,000 | 147,000,000 |
| Other payables | 125,400,000 | 154,400,000 | 111,400,000 | 96,100,000 |
| Accrued expenses | 470,600,000 | 535,600,000 | 476,100,000 | 380,100,000 |
| Short-term debt | 39,000,000 | 33,500,000 | 0 | 0 |
| Capital lease obligations (current) | 0 | 0 | 0 | 0 |
| Tax payables | 125,400,000 | 0 | 111,400,000 | 96,100,000 |
| Deferred revenue | 506,700,000 | 468,800,000 | 446,100,000 | 397,300,000 |
| Other current liabilities | 609,400,000 | 359,600,000 | 436,400,000 | 401,600,000 |
| Total current liabilities | 2,006,200,000 | 1,745,300,000 | 1,658,700,000 | 1,422,100,000 |
| Long-term debt | 131,900,000 | 0 | 0 | 0 |
| Capital lease obligations (non-current) | 131,900,000 | 112,500,000 | 0 | 0 |
| Deferred revenue (non-current) | 91,400,000 | 54,100,000 | 45,600,000 | 41,000,000 |
| Deferred tax liabilities (non-current) | 172,500,000 | 95,400,000 | 0 | 0 |
| Other non-current liabilities | 155,600,000 | 301,700,000 | 339,900,000 | 398,300,000 |
| Total non-current liabilities | 683,300,000 | 563,700,000 | 385,500,000 | 439,300,000 |
| Other liabilities | 0 | 0 | 0 | 0 |
| Capital lease obligations | 131,900,000 | 112,500,000 | 0 | 0 |
| Total liabilities | 2,689,500,000 | 2,309,000,000 | 2,044,200,000 | 1,861,400,000 |
| Treasury stock | 0 | 0 | 0 | 0 |
| Preferred stock | 0 | 0 | 0 | 0 |
| Common stock | 400,000 | 400,000 | 400,000 | 400,000 |
| Retained earnings | 7,011,800,000 | 6,803,300,000 | 4,743,000,000 | 3,500,100,000 |
| Additional paid-in capital | 10,768,500,000 | 9,681,300,000 | 8,576,400,000 | 7,703,900,000 |
| Accumulated other comprehensive income/loss | 43,300,000 | -51,300,000 | -12,200,000 | -162,500,000 |
| Other stockholders' equity | 0 | 0 | 0 | 0 |
| Total stockholders' equity | 17,824,000,000 | 16,433,700,000 | 13,307,600,000 | 11,041,900,000 |
| Total equity | 17,941,700,000 | 16,529,599,999 | 13,397,300,000 | 11,112,600,000 |
| Minority interest | 117,700,000 | 95,900,000 | 89,700,000 | 70,700,000 |
| Total liabilities and total equity | 20,631,200,000 | 18,838,600,000 | 15,441,500,000 | 12,974,000,000 |
| Total investments | 5,865,400,000 | 7,050,500,000 | 4,593,100,000 | 5,164,600,000 |
| Total debt | 302,800,000 | 146,000,000 | 0 | 0 |
| Net debt | -3,065,200,000 | -1,881,400,000 | -2,750,100,000 | -1,581,200,000 |
Intuitive Surgical, Inc. Cash Flow Statement
Cash from operations
Cash from investing
Cash flow / share TTM
—
Revenue / share TTM
—
Operating cash flow TTM
—
| Period end | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 |
|---|---|---|---|---|
| Cash from operations | 3,030,500,000 | 2,415,000,000 | 1,813,800,000 | 1,490,800,000 |
| Cash from investing | 665,800,000 | -3,272,800,000 | -360,100,000 | 1,370,800,000 |
| Cash from financing | -2,364,100,000 | 150,900,000 | -287,600,000 | -2,572,300,000 |
| Net change in cash | 1,345,000,000 | -707,700,000 | 1,169,400,000 | 294,700,000 |
All line items
| Line item | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 |
|---|---|---|---|---|
| Net income | 2,876,600,000 | 2,337,500,000 | 1,817,300,000 | 1,344,400,000 |
| Depreciation and amortization | 677,100,000 | 462,000,000 | 435,200,000 | 365,800,000 |
| Deferred income tax | 19,100,000 | -135,300,000 | -280,800,000 | -185,300,000 |
| Stock-based compensation | 788,200,000 | 676,800,000 | 598,200,000 | 513,200,000 |
| Change in working capital | -1,272,300,000 | -919,300,000 | -777,600,000 | -619,100,000 |
| Accounts receivable | -301,700,000 | -95,900,000 | -186,300,000 | -159,300,000 |
| Inventory | -1,063,400,000 | -830,000,000 | -712,500,000 | -546,600,000 |
| Accounts payable | 57,900,000 | -400,000 | 41,700,000 | 21,300,000 |
| Other working capital | 34,900,000 | 7,000,000 | 79,500,000 | 65,500,000 |
| Other non-cash items | -58,200,000 | -6,700,000 | 21,500,000 | 71,800,000 |
| Net cash from operating activities | 3,030,500,000 | 2,415,000,000 | 1,813,800,000 | 1,490,800,000 |
| Investments in property, plant and equipment | -539,800,000 | -1,111,200,000 | -1,064,200,000 | -532,400,000 |
| Acquisitions (net) | -13,900,000 | -1,000,000 | -8,900,000 | -12,800,000 |
| Purchases of investments | -1,215,900,000 | -5,139,600,000 | -2,207,400,000 | -1,399,500,000 |
| Sales/maturities of investments | 2,435,400,000 | 2,979,000,000 | 2,920,400,000 | 3,315,500,000 |
| Other investing activities | 0 | 0 | 0 | 0 |
| Net cash from investing activities | 665,800,000 | -3,272,800,000 | -360,100,000 | 1,370,800,000 |
| Net debt issuance | 0 | 0 | 0 | 0 |
| Long-term net debt issuance | 0 | 0 | 0 | 0 |
| Short-term net debt issuance | 0 | 0 | 0 | 0 |
| Net stock issuance | -1,945,000,000 | 429,400,000 | -120,000,000 | -2,373,600,000 |
| Net common stock issuance | -1,945,000,000 | 429,400,000 | -120,000,000 | -2,607,400,000 |
| Common stock issuance | 350,300,000 | 429,400,000 | 296,300,000 | 0 |
| Common stock repurchased | -2,295,300,000 | 0 | -416,300,000 | -2,607,400,000 |
| Net preferred stock issuance | 0 | 0 | 0 | 233,800,000 |
| Net dividends paid | 0 | 0 | 0 | 0 |
| Common dividends paid | 0 | 0 | 0 | 0 |
| Preferred dividends paid | 0 | 0 | 0 | 0 |
| Other financing activities | -419,100,000 | -278,500,000 | -167,600,000 | -198,700,000 |
| Net cash from financing activities | -2,364,100,000 | 150,900,000 | -287,600,000 | -2,572,300,000 |
| Effect of FX changes on cash | 12,800,000 | -800,000 | 3,300,000 | 5,400,000 |
| Net change in cash | 1,345,000,000 | -707,700,000 | 1,169,400,000 | 294,700,000 |
| Cash at end of period | 3,407,400,000 | 2,062,400,000 | 2,770,100,000 | 1,600,700,000 |
| Cash at beginning of period | 2,062,400,000 | 2,770,100,000 | 1,600,700,000 | 1,306,000,000 |
| Operating cash flow | 3,030,500,000 | 2,415,000,000 | 1,813,800,000 | 1,490,800,000 |
| Capital expenditure | -539,800,000 | -1,111,200,000 | -1,064,200,000 | -532,400,000 |
| Free cash flow | 2,490,700,000 | 1,303,800,000 | 749,600,000 | 958,400,000 |
| Income taxes paid | 537,900,000 | 466,500,000 | 447,800,000 | 444,200,000 |
| Interest paid | 0 | 0 | 0 | 0 |